Thoraxklinik Heidelberg gGmbH — Clinical Trial Site

127 Registered trials

52 Currently recruiting

Organisation

Thoraxklinik Heidelberg gGmbH

Location

Heidelberg, Germany

Identifier

ORG-100031900

Address

Roentgenstrasse 1, Rohrbach, 69126, Germany

Departments

1200:Innere Medizin/ Onkologie
Abteilung Pneumologie und Beatmungsmedizin
am Universitätsklinikum Heidelberg
Centre for Pulmonary Hypertension
Dep. Thoracic Oncology/Internal Medicine
Department of Pneumology and Critical Care Medicine
Department of Pneumology and Respiratory Medicine
Department of Thoracic Oncology
Department of Thoracic Surgery
Dept. of Thoracic Oncology
Gebäude 1
Haematologie und Internistische Onkologie
Innere Medizin - Onkologie
Internal Medicine - Thoracic oncology
Internal Medicine, Pulmonology and Critical Care Medicine
Internistische Onkologie der Thoraxtumoren
Klinik für Pneumologie und Beatmungsmedizin
Lungenkrebszentrum
N/A
NA
Oncology
Onkologie
Onkologie der Thoraxtumoren
Pneumologie und Beatmungsmedizin
Pneumology
Pulmonology Department
Studienzentrum ThoraxKliPS
Studienzentrum Thoraxonkologie
Studienzentum Thorxonkologie
Thoracic Oncolgy
Thoracic Oncology
Thoracic Surgery
Thoraxklinik
Thoraxklinik Heidelberg
Thoraxklinik Heidelberg gGmbH
Thoraxklinik Heidelberg gGmbH am Universitätsklinikum Heidelberg Zentrum für pulmonale Hypertonie
Thoraxklinik Heidelberg gGmbH, Studienzentrum Thoraxonkologie
Thoraxklinik/Thoraxonkologie Mesotheliomeinheit des NCT
ThoraxKliPS
Thoraxonkologie
Thoraxonkologie Heidelberg
Thoraxonkologisches Studienzentrum
Translationale Pneumologie
Universitaetsklinikum Heidelberg
Universitätskliniken Heidelberg, Thoraxklinik, Sektion für Pulmonale Hypertonie
Universitätsklinikum Heidelberg
Universitätsklinikum Heidelberg Zentrum für pulmonale Hypertonie
Universitätsklinikum Heidelberg Zentrum für pulmonale Hypertonie
Zentrum für Pulmolare Hypertonie
Zentrum für pulmonale Hypertonie

Clinical trials at this site (127)

Search interface

A phase 3 trial comparing a therapeutic cancer vaccine OSE2101 to chemotherapy docetaxel in patients with metastatic Non-Small Cell Lung Can… Recruiting

2023-509340-10-00 Patients with HLA-A2 positive phenotype and metastatic 5 2024-10-29
Maintenance of durvalumab and olaparib after standard 1st line treatment (carboplatin/ cisplatin, etoposide, durvalumab) in HRD positive ext… Recruiting

2024-512373-27-00 Advanced/inoperable or metastatic small-cell lung cance 4 2024-09-30
A follow-up study to test long-term treatment with BI 1015550 in people with pulmonary fibrosis who took part in a previous study with BI 10… Recruiting

2023-507353-15-00 idiopathic pulmonary fibrosis (IPF) 5 2024-09-10
Study of RMC-6291 and RMC-6236 With Other Anti-Cancer Agents in Patients With RAS G12C-Mutated NSCLC - Subprotocol A Recruiting

2023-509571-16-00 Lung Cancer 3 2024-07-17
A study of RMC-6236 in combination with pembrolizumab in participants with nonsmall cell lung cancer with certain mutations -Subprotocol B Recruiting

2023-509572-42-00 Lung Cancer 3 2024-07-17
Randomized trial comparing efficacy and safety of initial triple therapy including parenteral treprostinil to initial double oral therapy in… Recruiting

2023-504351-26-01 Pulmonary arterial hypertension (group I) 11 2023-12-06
A Phase I/II First-In-Human Clinical Trial to Evaluate the Safety, Tolerability and Anti-Tumor Activity of IMA402, a Bispecific T Cell-Engag… Recruiting

2022-503133-54-00 Solid Tumors 7 2023-08-09
A Phase 1/2 Study of the Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor NVL-655 in Patients with Advanced NSCLC and Other Solid Tumors… Recruiting

2024-514266-39-00 Advanced Non-Small Cell Lung Cancer (NSCLC) and Other S 7 2022-11-03
Pan tumor Roll Over Study Recruiting

2023-506914-32-00 Pan tumor 4 2020-05-05
A clinical study of sotatercept in people with pulmonary arterial hypertension (MK-7962-038) Ended

2025-521970-33-00 Pulmonary Arterial Hypertension (PAH) 5 2025-12-19
A clinical study of sotatercept in people with pulmonary hypertension (MK-7962-023) Ended

2024-515773-99-00 Pulmonary Hypertension 4 2025-05-26
A Study to Learn How the Study Medicine Called PF-07868489 is Tolerated and Acts in Healthy Adult People and People With Pulmonary Arterial … Ended

2024-514064-17-00 Pulmonary Arterial Hypertension 3 2025-05-23
BMS-986489 (BMS-986012 + Nivolumab Fixed Dose Combination) with Chemotherapy vs Atezolizumab with Chemotherapy as First-line Therapy in Part… Ended

2024-515740-23-00 Extensive-Stage Small Cell Lung Cancer (ES-SCLC) 5 2025-03-25
AMG 193 Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protoco… Ended

2024-511253-21-00 Thoracic tumors with homozygous MTAP-deletion 3 2025-02-28
A Phase 2, Randomized, Placebo-Controlled Trial to Assess the Efficacy and Safety of Mosliciguat in Participants with Pulmonary Hypertension… Ended

2024-513991-16-00 Pulmonary Hypertension Associated with Interstitial Lun 4 2025-01-17
A trial to evaluate efficacy and safety of buloxibutid in people with idiopathic pulmonary fibrosis Ended

2023-509069-19-00 idiopathic pulmonary fibrosis 4 2024-12-12
Study Comparing Tarlatamab and Durvalumab versus Durvalumab Alone in First Line ES-SCLC Following Platinum, Etoposide and Durvalumab (DeLLph… Ended

2023-505989-29-00 Extensive stage small cell lung cancer (ES-SCLC) 5 2024-11-21
HARMONi-3 Ended

2024-513087-26-00 Metastatic Non-small Cell Lung Cancer 5 2024-09-10
A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Patients with previously treated KRAS G12C-positive… Ended

2024-510908-37-00 KRAS G12C-Positive Advanced or Metastatic Non-Small Cel 5 2024-08-28
An Open-label Extension Study Evaluating the Long-term Safety and Efficacy of Seralutinib Orally Inhaled for the Treatment of Pulmonary Arte… Ended

2023-506334-75-00 Pulmonary Arterial Hypertension 5 2024-07-12
Phase III Trial of Volrustomig (MEDI5752) in Combination with Carboplatin plus Pemetrexed vs. Investigator’s Choice of the Standard of Care … Ended

2023-503231-17-00 Unresectable Pleural Mesothelioma 5 2024-04-26
Randomized open-label Phase 2 trial evaluating the impact of enhanced versus standard dermatologic management on selected dermatologic adver… Ended

2023-505863-35-00 EGFR-mutated Advanced or Metastatic Non-small Cell Lung 4 2024-03-20
A study of sigvotatug vedotin versus docetaxel in previously treated non-small cell lung cancer (Be6A Lung-01) Ended

2023-503827-25-01 Non-Small Cell Lung Cancer (NSCLC) 5 2024-02-16
DAREONTM-9: A study to test how well different doses of BI 764532 are tolerated by people with small cell lung cancer when taken together w… Ended

2023-506007-26-00 relapsed/refractory extensive stage - small cell lung c 3 2024-01-15